The European Medicines Agency (EMA) recommended on Friday to convert the current conditional license granted to Pfizer and Moderna to use their vaccines against COVID-19 in the European Union (EU) into a standard authorization, which does not require no more annual renewal.

The Committee for Medicinal Products for Human Use, which supported a conditional license for Pfizer (December 2020) and Moderna (January 2021) due to the health emergency caused by the pandemic, now considers that authorizations for the two vaccines can become “standard “, which “they no longer need to be renewed annually”, although the other obligations for the two companies “remain in force”.

By admin

Leave a Reply

Your email address will not be published.